Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 13, 2026
Low Incidence of Relapses After Vaccination in Anti-Aquaporin-4 Antibody-Positive NMOSD.
Journal: Annals of clinical and translational neurology
Published: December 18, 2025
Immediate and sustained terminal complement inhibition with ravulizumab in patients with anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder.
Journal: Frontiers in neurology
Published: November 03, 2023
Dimethyl fumarate treatment shifts the immune environment toward an anti-inflammatory cell profile while maintaining protective humoral immunity.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 28, 2020
Safety and efficacy of daclizumab beta in patients with relapsing multiple sclerosis in a 5-year open-label study (EXTEND): final results following early termination.
Journal: Therapeutic advances in neurological disorders
Published: June 17, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Hispanic or Latino Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Journal: Neurology and therapy
Published: April 02, 2020
Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM.
Journal: Neurology and therapy
Published: April 02, 2020
Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.
Journal: Therapeutic advances in neurological disorders
Published: October 04, 2019
Effectiveness of alternative dose fingolimod for multiple sclerosis.
Journal: Neurology. Clinical practice
Published: September 06, 2017
Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: July 20, 2017
The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study.
Journal: Neurology
Published: January 28, 2016
Dimethyl fumarate-associated lymphopenia: Risk factors and clinical significance.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: November 10, 2015
Last Updated: 09/26/2026